UMCD-6

N/A

Report date: 2025/01/26 16:42:32

Base Information

Drug NameUMCD-6
Drug Alias NameT-cell differentiation antigen CD6 inhibitor University of MichiganUMCD-6
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionT-cell differentiation antigen CD6 inhibitors
TargetsT-cell differentiation antigen CD6
Therapy Area/IndicationsProstatic NeoplasmsLung NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Michigan
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsLung NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A